SUBSCRIBE
SUBSCRIBE

Pfizer

NEWS
Policy
Biopharma Update on the Novel Coronavirus: August 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
August 11, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: August 7
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 7, 2020.
August 6, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Policy
With Court Win, BMS and Pfizer Stave Off Eliquis Generic Challengers – For Now
Eliquis generic was approved by FDA to prevent strokes, blood clots etc. But there were some legal issues which recently got stave off. Know more about it here.
August 6, 2020
 · 
2 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: August 5
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 5, 2020.
August 4, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Business
Pfizer Spinoff Cerevel Merges with Arya Sciences and Goes Public
Cerevel Therapeutics, which spun out of Pfizer two years ago, entered into a business combination deal with Arya Sciences Acquisition Corp II, a special purpose acquisition company (SPAC) sponsored by Perceptive Advisors.
July 31, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: July 31
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 31, 2020.
July 30, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: July 29
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 29, 2020.
July 29, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Pfizer and BioNTech Begin Global Phase II/III COVID-19 Vaccine Trial
The vaccine will be dosed at a 30-microgram level with a two-dose regimen. The vaccine is an mRNA product, with the mRNA encoding for the SARS-CoV-2 full length spike glycoprotein (S).
July 28, 2020
 · 
3 min read
 · 
Mark Terry
BioCapital
Clinical Catch-Up: July 20-24
It was a busy week for clinical trial news, with some very important early-stage trial data for various COVID-19 vaccines. Here’s a look.
July 24, 2020
 · 
8 min read
 · 
Mark Terry
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Flagship Pioneering and Repertoire® Immune Medicines Announce Agreement to Identify T Cell-Targeted Immune Medicines for Prostate Cancer Under Strategic Partnership with Pfizer
December 23, 2025
 · 
4 min read
Press Releases
Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts
December 19, 2025
 · 
3 min read
Press Releases
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
December 17, 2025
 · 
19 min read
Press Releases
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
December 16, 2025
 · 
5 min read
Press Releases
Pfizer Declares First-Quarter 2026 Dividend
December 15, 2025
 · 
1 min read
Press Releases
TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer
December 11, 2025
 · 
12 min read
Press Releases
Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma
December 10, 2025
 · 
5 min read
Press Releases
Fosun Pharma’s Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement
December 10, 2025
 · 
2 min read
Press Releases
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
December 8, 2025
 · 
16 min read
Press Releases
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance
December 2, 2025
 · 
3 min read
Load More